Full Text View
Tabular View
No Study Results Posted
Related Studies
Quantification of Liver Iron Overload and Steatosis Using Magnetic Resonance Imaging (SURFER)
This study is currently recruiting participants.
Verified by Rennes University Hospital, September 2008
First Received: November 17, 2006   Last Updated: September 29, 2008   History of Changes
Sponsors and Collaborators: Rennes University Hospital
Ministry of Health, France
Information provided by: Rennes University Hospital
ClinicalTrials.gov Identifier: NCT00401336
  Purpose

Iron excess is increasingly regarded as an important cofactor in the morbidity attributed to many disorders. Assessment of body iron stores by measurement of serum ferritin concentrations has poor specificity and the most reliable method is histological or biochemical assessment from a liver biopsy. Because liver biopsy is an invasive procedure, imaging methods have been developed to detect and quantify hepatic iron content. The aim of the study is to use a simplified magnetic resonance imaging (MRI) technique to quantify simultaneously iron and fat contents in the liver and to compare the results to the quantification obtained biochemically.


Condition Intervention
Iron Overload
Metabolic Syndrome X
Hepatitis B
Hepatitis C
Alcohol Abuse
Device: Magnetic resonance imaging multiecho gradient-echo sequence

MedlinePlus related topics: Hepatitis Hepatitis B Hepatitis C MRI Scans Metabolic Syndrome
U.S. FDA Resources
Study Type: Interventional
Study Design: Diagnostic, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment
Official Title: Quantification of Liver Iron Overload and Steatosis Using a New Magnetic Resonance Imaging Multiecho Gradient-Echo Sequence

Further study details as provided by Rennes University Hospital:

Primary Outcome Measures:
  • Liver to muscle signal intensity ratio and T2* calculation versus liver iron concentration [ Time Frame: during examination ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Difference between in-phase and out-phase T2* calculation versus liver fat concentration [ Time Frame: during examination ] [ Designated as safety issue: No ]
  • Correlation between biochemical and MRI quantification of liver iron [ Time Frame: during examination ] [ Designated as safety issue: No ]
  • Correlation between participating centers [ Time Frame: during examination ] [ Designated as safety issue: No ]
  • Reproducibility of the multiecho gradient-echo sequence [ Time Frame: during examination ] [ Designated as safety issue: No ]
  • Influence of the antenna for the multiecho gradient-echo sequence [ Time Frame: during examination ] [ Designated as safety issue: No ]

Estimated Enrollment: 250
Study Start Date: November 2006
Estimated Primary Completion Date: November 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Magnetic Resonance Imaging: Experimental
New magnetic resonance imaging multiecho gradient-echo sequence
Device: Magnetic resonance imaging multiecho gradient-echo sequence
Breath-hold gradient echo sequences with a single echo and a new multiple-echo gradient-echo sequence

Detailed Description:

Iron excess is increasingly regarded as an important cofactor in the morbidity attributed to many disorders. Assessment of body iron stores by measurement of serum ferritin concentrations has poor specificity and the most reliable method is histological or biochemical assessment from a liver biopsy. Because liver biopsy is an invasive procedure, imaging methods have been developed to detect and quantify hepatic iron content.

The aim of the study is to use a simplified magnetic resonance imaging technique to quantify simultaneously iron and fat contents in the liver and to compare the results to the quantification obtained biochemically. Patients who need a liver biopsy will be proposed to be enrolled in the study. A magnetic resonance (MR) study will be performed using breath-hold gradient echo sequences with a single echo and a new multiple-echo gradient-echo sequence. Liver and muscle MR signal will be quantitatively determined and compared to biochemical assessment of liver iron concentration and steatosis quantification.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adults over 18,
  • Planned for a liver biopsy for at least one of these indications: suspicion of liver iron overload, metabolic syndrome, hepatitis B or C, alcohol abuse,
  • Having given a written informed consent.

Exclusion Criteria:

  • Non cooperating patient,
  • Patient with dyspnea,
  • Patient with contra-indication to MR imaging (pace-maker, heart valve,...).
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00401336

Contacts
Contact: Yves Gandon, MD 33-2-9928-4261 yves.gandon@chu-rennes.fr
Contact: Eric Bellissant, MD, PhD 33-2-9928-9200 eric.bellissant@chu-rennes.fr

Locations
France
Hôpital de Pontchaillou Recruiting
Rennes, France, 35033
Contact: Yves Gandon, MD     33-2-9928-4261     yves.gandon@chu-rennes.fr    
Principal Investigator: Yves Gandon, MD            
Sub-Investigator: Fabrice Lainé, MD            
Sub-Investigator: Bruno Turlin, MD            
Sub-Investigator: Martine Ropert, MD            
CHU Angers Recruiting
Angers, France, 49033
Contact: Christophe Aubé, MD     33-1-4135-4279     ChAube@chu-angers.fr    
Principal Investigator: Christophe Aubé, MD            
Sub-Investigator: Sophie Michalak, MD            
Sub-Investigator: Paul Calès, MD            
Sub-Investigator: Frédéric Oberti, MD            
Sub-Investigator: Isabelle Fouchard-Hubert, MD            
Sub-Investigator: Jérôme Boursier, MD            
Hôpital Huriez Not yet recruiting
Lille, France, 59037
Contact: Olivier Ernst, MD     33-3-2044-6233     oernst@chru-lille.fr    
Principal Investigator: Olivier Ernst, MD            
Sub-Investigator: Philippe Mathurin, MD            
Sub-Investigator: Valérie Canva, MD            
Sub-Investigator: Sébastien Dharancy, MD            
Sub-Investigator: Emmanuelle Leteurtre, MD            
Hôpital Tenon Not yet recruiting
Paris, France, 75970
Contact: Franck Boudghene, MD     33-1-5601-7269     franck.boudghene@tnn.aphp.fr    
Principal Investigator: Franck Boudghene, MD            
Sub-Investigator: Patrice Callard, MD            
Sub-Investigator: Jean-Didier Grangé, MD            
Hôpital Beaujon Not yet recruiting
Clichy, France, 92118
Contact: Valérie Vilgrain, MD     33-1-4087-5358     valerie.vilgrain@bjn.aphp.fr    
Principal Investigator: Valérie Vilgrain, MD            
Sub-Investigator: Dominique Cazals, MD            
Hôpital du Brabois Not yet recruiting
Vandoeuvre les Nancy, France, 54511
Contact: Valérie Laurent, MD     33-3-8315-4186     v_croiselaurent@yahoo.fr    
Sub-Investigator: Denis Regent, MD            
Principal Investigator: Valérie Laurent, MD            
Sub-Investigator: Jean-Pierre Bronowicki, MD            
Sub-Investigator: François Plénat, MD            
Hôpital de la Timone Not yet recruiting
Marseille, France, 13385
Contact: Philippe Petit, MD     33-4-9138-6797     ppetit@ap-hm.fr    
Principal Investigator: Philippe Petit, MD            
Sub-Investigator: Jean-François Pelissier, MD            
Hôpital Edouard Herriot Recruiting
Lyon, France, 69003
Contact: Franck Pilleul, MD     33-4-7211-7540     franck.pilleul@chu-lyon.fr    
Principal Investigator: Franck Pilleul, MD            
Sub-Investigator: Pierre-Jean Valette, MD            
Sub-Investigator: Jérôme Dumortier, MD            
Sub-Investigator: Jean-Yves Scoazec, MD            
Hôpital Saint Eloi Not yet recruiting
Montpellier, France, 34000
Contact: Benoît Gallix, MD     33-4-6733-7119     b-gallix@chu-montpellier.fr    
Principal Investigator: Benoît Gallix, MD            
Sub-Investigator: Pierre Baldet, MD            
Sub-Investigator: Georges-Philippe Pageaux, MD            
Sponsors and Collaborators
Rennes University Hospital
Ministry of Health, France
Investigators
Study Director: Yves Gandon, MD Rennes University Hospital
Study Chair: Eric Bellissant, MD, PhD Rennes University Hospital
  More Information

No publications provided

Responsible Party: Rennes University Hospital ( Direction of Clinical Research )
Study ID Numbers: DGS 2006/0197, PHRC/04-08, CIC0203/044
Study First Received: November 17, 2006
Last Updated: September 29, 2008
ClinicalTrials.gov Identifier: NCT00401336     History of Changes
Health Authority: France: Direction Générale de la Santé

Keywords provided by Rennes University Hospital:
Magnetic resonance imaging
Hepatic iron
Steatosis

Study placed in the following topic categories:
Liver Diseases
Metabolic Diseases
Metabolic Syndrome X
Disorders of Environmental Origin
Hepatitis, Viral, Human
Iron Metabolism Disorders
Abdominal Obesity Metabolic Syndrome
Hepatitis
Virus Diseases
Hyperinsulinism
Digestive System Diseases
Mental Disorders
Alcoholism
Hepatitis B
Substance-Related Disorders
DNA Virus Infections
Alcohol-Related Disorders
Insulin Resistance
Hepatitis C
Iron Overload
Glucose Metabolism Disorders
Iron
Metabolic Disorder

Additional relevant MeSH terms:
Liver Diseases
Flaviviridae Infections
Hepatitis, Viral, Human
Disorders of Environmental Origin
Iron Metabolism Disorders
Hepadnaviridae Infections
Hyperinsulinism
Pathologic Processes
Mental Disorders
Syndrome
Hepatitis B
Substance-Related Disorders
Alcohol-Related Disorders
Hepatitis C
RNA Virus Infections
Metabolic Syndrome X
Disease
Metabolic Diseases
Virus Diseases
Hepatitis
Digestive System Diseases
Alcoholism
DNA Virus Infections
Iron Overload
Insulin Resistance
Glucose Metabolism Disorders

ClinicalTrials.gov processed this record on May 06, 2009